1. Home
  2. BCRX vs DCO Comparison

BCRX vs DCO Comparison

Compare BCRX & DCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

HOLD

Current Price

$9.81

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo Ducommun Incorporated

DCO

Ducommun Incorporated

HOLD

Current Price

$139.19

Market Cap

1.9B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCRX
DCO
Founded
1986
1849
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Military/Government/Technical
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.9B
IPO Year
1995
1995

Fundamental Metrics

Financial Performance
Metric
BCRX
DCO
Price
$9.81
$139.19
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
5
Target Price
$20.82
$149.80
AVG Volume (30 Days)
5.9M
152.3K
Earning Date
05-04-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
381.40
N/A
EPS
1.21
N/A
Revenue
$25,186,000.00
$824,730,000.00
Revenue This Year
N/A
$7.40
Revenue Next Year
$12.55
$8.59
P/E Ratio
$8.07
N/A
Revenue Growth
N/A
4.85
52 Week Low
$6.00
$53.71
52 Week High
$11.31
$143.33

Technical Indicators

Market Signals
Indicator
BCRX
DCO
Relative Strength Index (RSI) 64.16 67.40
Support Level $7.85 $87.68
Resistance Level $10.32 $140.02
Average True Range (ATR) 0.56 4.75
MACD -0.05 1.34
Stochastic Oscillator 63.99 85.11

Price Performance

Historical Comparison
BCRX
DCO

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

About DCO Ducommun Incorporated

Ducommun Inc provides engineering & manufacturing services for high-performance products & high-cost-of failure applications used in the aerospace and defense, industrial, medical & other industries. The company's reportable segments are Structural Systems & Electronic Systems. Structural Systems designs, engineers and manufactures various sizes of complex contoured aerostructure components and assemblies and supplies composite and metal bonded structures and assemblies. Electronic Systems designs, engineers and manufactures high-reliability electronic and electromechanical products used in technology-driven markets including A&D and Industrial end-use markets. It generates maximum of its revenue from the Electronic Systems.

Share on Social Networks: